w.novak

TL3 Regular · Brno, CZ

Engineer. I like unit arithmetic and I dislike unlabelled axes.

Joined 6 January 2025 · last posted 2d · groups: wiki-editors

125 posts, newest first. Showing up to 150.

Tracking intake honestly when appetite is absent Replied, post #114 · Nutrition & Training › Protein & intake · 26 Jul 2026 · 16 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Impurity thresholds: where the common numbers come from Replied, post #15 · Analytics › Impurities & related substances · 25 Jul 2026 · 20 likes A supplier that can tell you what its principal impurity is has answered a harder question than one that can tell you its purity, and the answer is more useful.
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #35 · Clinical › Bloodwork · 25 Jul 2026 · 15 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #138 · Practice › Reconstitution · 24 Jul 2026 · 0 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
Why the Start Here categories exist, and what they are not for Replied, post #27 · Start Here › Welcome · 23 Jul 2026 · 33 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #72 · Evidence › Journal club · 22 Jul 2026 · 9 likes Two things can be true about STEP 1 at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #87 · Analytics › Impurities & related substances · 17 Jul 2026 · 3 likes That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude it, and no certificate says which species its…
Retatrutide mass and identity: what a report should show Replied, post #16 · Compounds › Retatrutide · 13 Jul 2026 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #65 · Access › Insurance & coverage · 10 Jul 2026 · 0 likes An update on my earlier Prior authorisation post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
Substitution between formats during a shortage — what changed since Replied, post #5 · Access › Shortages · 9 Jul 2026 · 5 likes Everything in post #3 holds. The case it does not cover is the one I have. The published shortage register maintained by the national regulator is the authoritative…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #6 · Clinical › Comorbidities · 9 Jul 2026 · 4 likes Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.
Revisiting: Protein density versus volume when you cannot eat much Replied, post #45 · Nutrition & Training › Protein & intake · 9 Jul 2026 · 0 likes I read the earlier replies on Protein density versus volume twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with…
Follow-up: Sleep quality changes during weight loss Replied, post #54 · Wellbeing › Sleep · 26 Jun 2026 · 0 likes Picking up post #52: that is the part I would want checked first. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to…
Revisiting: What pooling buys you and what it destroys Replied, post #65 · Evidence › Meta-analyses · 23 Jun 2026 · 0 likes Building on post #64 rather than restating it. Worth stating the null on pooling buys before we explain it: the observation may be nothing. That possibility deserves a…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #67 · Practice › Storage & stability · 6 Jun 2026 · 0 likes Picking up post #66: that is the part I would want checked first. Reading this reconstituted thread as someone who came in with a fixed view: the third and seventh…
An appeal that succeeded, with the letter structure — the long version Replied, post #24 · Access › Insurance & coverage · 28 May 2026 · 7 likes On appeal: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
Request: a per-category review queue Started this topic · Meta › Feature requests · 22 May 2026 · 0 likes Request: a per-category review queue Writing it up because I had to work it out twice and would rather nobody else did. Per-category review queue — I have the…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #41 · Analytics › Impurities & related substances · 18 May 2026 · 7 likes Post #37 put the caveat in the right place and I want to underline it. Residual solvents and scavengers has been discussed here with more heat than it deserves, mostly…
Second pass at: A pooled estimate that changed when one trial was added Replied, post #4 · Evidence › Meta-analyses · 12 May 2026 · 5 likes I read the opening post twice before replying, because I had assumed the opposite. Adding the boring version of pooled estimate, because the interesting version keeps…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #102 · Practice › Interactions · 8 May 2026 · 1 like Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people. If the premise is…
What a certificate commits its issuer to — one year on Replied, post #62 · Analytics › COA interpretation · 5 May 2026 · 18 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #84 · Devices › Syringes & needles · 3 May 2026 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Electrolyte supplements: which ones do anything Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 3 May 2026 · 22 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #40 · Sourcing › Red flags · 3 May 2026 · 0 likes I read post #36 twice before replying, because I had assumed the opposite. Evasion when asked: if a supplier does not clarify when asked specifically for method…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #107 · Compounds › Tirzepatide · 2 May 2026 · 26 likes The thing about 2.5 mg starting dose that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #35 · Meta › Announcements · 23 Apr 2026 · 18 likes If you are new and reading this thread for the answer to Trust level 3 requirements: the answer is conditional, the conditions are in the third reply, and the rest of…
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #14 · Lounge › Introductions · 18 Apr 2026 · 3 likes Nice to meet you. Say what you are interested in rather than what you do, if you would rather — plenty of people here are anonymous about their background and it costs…
Micro-titration: a disputed topic, argued properly Replied, post #56 · Practice › Dosing & titration · 6 Apr 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #17 · Practice › Interactions · 29 Mar 2026 · 14 likes Bookmarking this. I will come back when I have something worth adding.
Designing a personal experiment that could change your mind — one year on Replied, post #24 · Research Methods › N-of-1 designs · 23 Mar 2026 · 2 likes Narrowing post #23, because the general version has more than one answer. Designing a personal experiment is a question about a distribution, not about a value, and…
What a certificate commits its issuer to — one year on Replied, post #35 · Analytics › COA interpretation · 20 Mar 2026 · 7 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Second pass at: The topic list is dense — is that deliberate? Replied, post #94 · Meta › Site feedback · 9 Mar 2026 · 0 likes I changed my mind about topic list after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way…
Contributing data without breaching anyone's privacy Replied, post #29 · Data & Tools › Datasets · 4 Mar 2026 · 2 likes Coming back to post #25, because the follow-up matters more than the original answer. Self-reported, unblinded, self-selected data has known biases and is still worth…
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #30 · Practice › Storage & stability · 4 Mar 2026 · 15 likes I read post #28 twice before replying, because I had assumed the opposite. Container choice matters: the material of the vial, the rubber closure, the fill volume all…
Request: export my own posts — one year on Replied, post #54 · Meta › Feature requests · 3 Mar 2026 · 0 likes Answering the question post #50 raises rather than the one it answers. Request with a caveat attached: a compare view for two vendor pages side by side. The caveat is…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #10 · Sourcing › Logistics · 3 Mar 2026 · 5 likes Practical note on Regional warehouse stock versus direct: write down what you expect before you look. The number of times I have found what I went looking for is higher…
Lipase elevation without symptoms: the interpretation problem Replied, post #25 · Clinical › Bloodwork · 3 Mar 2026 · 26 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
Peer-to-peer review: what actually happens on the call — one year on Replied, post #6 · Access › Insurance & coverage · 2 Mar 2026 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #40 · Analytics › Impurities & related substances · 25 Feb 2026 · 0 likes Confirming post #39 from a second method, which matters more than confirming it from a second person. Reframing impurities in solid-phase peptide synthesis slightly,…
Liver enzymes drifting down and what that usually means Replied, post #60 · Clinical › Bloodwork · 24 Feb 2026 · 7 likes No notes. Posting so the count is not one.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #60 · Practice › Dosing & titration · 18 Feb 2026 · 17 likes Post #57 describes the usual case. This is about the unusual one. Nothing here is medical advice, and a titration question is one of the few where a prescriber can…
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #8 · Sourcing › Vendor reports · 18 Feb 2026 · 2 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. I would want the raw data before agreeing with my own…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #67 · Documentation › Wiki requests · 2 Feb 2026 · 2 likes Review cadence should be part of the proposal. A page about a fast-moving area needs a shorter cycle and somebody willing to honour it.
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #20 · Outcomes › Body composition · 29 Jan 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Coverage in the US: a map of the usual obstacles Replied, post #43 · Regional › North America · 29 Jan 2026 · 4 likes Offering a way to settle coverage rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
A partial dose because the pen emptied mid-injection Replied, post #72 · Practice › Administration · 9 Jan 2026 · 2 likes A definition problem is doing most of the work in this partial dose because the pen discussion. Once the term is pinned down I suspect the disagreement mostly goes away…
A partial dose because the pen emptied mid-injection Replied, post #65 · Practice › Administration · 9 Jan 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. The…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #40 · Pharmacology › Receptor biology · 3 Jan 2026 · 3 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #29 · Practice › Interactions · 2 Jan 2026 · 0 likes My understanding of Common supplements is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #34 · Devices › Pens & autoinjectors · 25 Dec 2025 · 12 likes Marking my place. If it changes for me I will come back and say so.
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 22 Dec 2025 · 1 like Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #125 · Practice › Reconstitution · 22 Dec 2025 · 3 likes Answering the question post #121 raises rather than the one it answers. For anyone finding this later: the short answer on decimal-point error is that it depends on one…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #118 · Practice › Reconstitution · 12 Dec 2025 · 28 likes Saving this. It is the version I will quote when the question comes round again.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #27 · Compounds › Tirzepatide · 3 Dec 2025 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #23 · Devices › Pens & autoinjectors · 30 Nov 2025 · 27 likes The arithmetic in post #20 is right; the assumption feeding it is the part to check. Comparing cost per milligram between a pen and a vial ignores wastage, dead volume…
Personal import allowances, compared — a second dataset Replied, post #26 · Access › International · 23 Nov 2025 · 0 likes Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one. The rule of thumb is…
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #45 · Analytics › Impurities & related substances · 23 Nov 2025 · 0 likes Oxidation at methionine or tryptophan adds sixteen per oxygen and typically elutes earlier. In aged material it is the modification that grows.
[2026 update] What steady state means for the decision to escalate Replied, post #122 · Practice › Dosing & titration · 17 Nov 2025 · 0 likes I read post #118 twice before replying, because I had assumed the opposite. Worth separating steady state as a question about the compound from steady state as a…
Sleep quality changes during weight loss — what changed since Replied, post #55 · Wellbeing › Sleep · 8 Nov 2025 · 0 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #10 · Compounds › Retatrutide · 29 Oct 2025 · 17 likes Where I part company with post #8, and it is a narrow parting. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates,…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #81 · Documentation › Doc review · 25 Oct 2025 · 10 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. I keep a log of this specifically because…
A 40-week log with the measurement method stated Replied, post #60 · Outcomes › Progress reports · 24 Oct 2025 · 1 like That matches what I have seen, for whatever a single anecdote is worth.
New subcategory: rationale and scope Replied, post #88 · Meta › Announcements · 22 Oct 2025 · 0 likes Reporting rather than recommending, on new subcategory. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
New subcategory: rationale and scope Replied, post #63 · Meta › Announcements · 19 Oct 2025 · 3 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
A parcel that arrived warm: a decision process, not a verdict Replied, post #92 · Practice › Storage & stability · 19 Oct 2025 · 19 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #31 · Practice › Interactions · 13 Oct 2025 · 0 likes Everything in post #27 holds. The case it does not cover is the one I have. A pharmacist can answer most questions in this subcategory in a few minutes with access to a…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #114 · Practice › Side effects · 3 Oct 2025 · 3 likes Nausea timeline was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #18 · Evidence › Preprints · 26 Sep 2025 · 21 likes I read post #14 twice before replying, because I had assumed the opposite. A preprint reporting a null result is more likely to stay a preprint, which biases the…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #7 · marked as the solution · Evidence › Preprints · 25 Sep 2025 · 7 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
Dead volume across syringe and needle combinations Replied, post #4 · Devices › Syringes & needles · 23 Sep 2025 · 6 likes The opening post and I disagree about the size of the effect, not about the direction. The useful distinction on dead volume across syringe is between what was measured…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #81 · Practice › Side effects · 9 Sep 2025 · 0 likes Nobody has said the unglamorous part of Fatigue yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Where impurities in solid-phase peptide synthesis come from Replied, post #6 · Analytics › Impurities & related substances · 5 Sep 2025 · 0 likes That is a fair summary of where the discussion has got to.
A request that was declined, and the reasoning — a second dataset Replied, post #97 · Documentation › Wiki requests · 15 Aug 2025 · 3 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it. The answer changed when I changed how I was measuring,…
A request that was declined, and the reasoning — a second dataset Replied, post #50 · Documentation › Wiki requests · 11 Aug 2025 · 0 likes Scope the request narrowly. A page about one thing gets written and stays current; a page about a field does not. That holds for the case as described. Change the…
Coming back to: An 18-month record including the parts that went badly Replied, post #80 · Outcomes › Progress reports · 15 Jul 2025 · 16 likes The version of 18-month record that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #67 · Clinical › Comorbidities · 8 Jul 2025 · 17 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
Checking someone else's arithmetic: a worked example thread Replied, post #62 · Practice › Reconstitution · 29 Jun 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Noting that…
Coming back to: When "no data" is the complete and final answer Replied, post #27 · Compounds › Other compounds · 28 Jun 2025 · 0 likes Answering the question post #25 raises rather than the one it answers. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
A report I filed that turned out to be wrong, and the correction Replied, post #118 · Sourcing › Vendor reports · 23 Jun 2025 · 8 likes Post #116 answers the question as asked. The question underneath it is different. Comparing your result to somebody else's on a different lot is not a comparison of…
Counter-ion content and its effect on measured mass Replied, post #67 · Analytics › Mass spectrometry · 17 Jun 2025 · 26 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.
Half-life, steady state, and accumulation worked through Replied, post #109 · Pharmacology › Pharmacokinetics · 13 Jun 2025 · 2 likes The thing about half-life that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
[2026 update] An appeal that failed, and what I would do differently Replied, post #33 · Access › Insurance & coverage · 9 Jun 2025 · 0 likes I had written a reply contradicting post #31 and deleted it. Here is what survived. Documentation your clinician can provide: letters from clinicians describing why…
Which panel is worth repeating and which is worth ignoring Replied, post #32 · Clinical › Bloodwork · 5 Jun 2025 · 0 likes I would put moderate confidence on the mainstream reading of panel and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
Sequence verification for an obscure compound: how it is done Replied, post #51 · Compounds › Other compounds · 2 Jun 2025 · 3 likes This follows post #50 rather than contradicting it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #3 · Sourcing › Vendor reports · 17 May 2025 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #96 · Sourcing › Red flags · 16 May 2025 · 2 likes Confirming post #94 from a second method, which matters more than confirming it from a second person. Anonymous accusations get hidden under the guidelines and the…
Reading an MS report that only gives you a single number Replied, post #77 · Analytics › Mass spectrometry · 12 May 2025 · 0 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
A vial that will not fully dissolve: what to check and in what order Replied, post #17 · Practice › Reconstitution · 9 May 2025 · 15 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #15 · Evidence › Trials · 21 Apr 2025 · 0 likes Right, and stated more narrowly than I would have dared to state it.
When to suspect the method rather than the sample Replied, post #116 · Analytics › Method validation · 17 Apr 2025 · 21 likes Adding a data point of agreement rather than a data point.
Journal club: SURMOUNT-1, read without the press release Replied, post #92 · Evidence › Journal club · 7 Apr 2025 · 15 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
Storing a pen in use versus a pen unopened Replied, post #6 · Devices › Pens & autoinjectors · 4 Apr 2025 · 17 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen. That has been…
Coverage for the indication versus for the drug Replied, post #16 · Access › Insurance & coverage · 1 Apr 2025 · 1 like Worth separating two things that post #14 runs together. Second-hand on coverage, so weight it accordingly — someone whose method I trust told me this and I have not…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #66 · Practice › Reconstitution · 29 Mar 2025 · 15 likes Helpful, and short, which on this subject is harder than long.
Coverage for the indication versus for the drug — a second dataset Replied, post #37 · Access › Insurance & coverage · 23 Mar 2025 · 27 likes Where I have landed on Coverage, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed…
Review: a draft on reconstitution arithmetic, with objections Replied, post #71 · Documentation › Doc review · 23 Mar 2025 · 0 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #126 · Pharmacology › Receptor biology · 19 Mar 2025 · 13 likes Confirming post #123 from a second method, which matters more than confirming it from a second person. Glucagon receptor agonism: glucagon receptor agonism increases…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #76 · Sourcing › Vendor reports · 17 Mar 2025 · 3 likes On post #72 — agreed on the reasoning, with one qualification. Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #37 · Analytics › Mass spectrometry · 17 Mar 2025 · 0 likes Post #36 is the version of this I will quote in future. One addition. Small correction to my own earlier position on adducts. I had the units the wrong way round, which…
Reading order for a first week here, and what to skip until later Replied, post #32 · Start Here › Welcome · 11 Mar 2025 · 27 likes Counterpoint on reading order, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #9 · Practice › Administration · 6 Mar 2025 · 9 likes Picking up post #8: that is the part I would want checked first. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #102 · Compounds › Other compounds · 28 Feb 2025 · 4 likes The version of Research-use-only status that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
Scheduled maintenance and what will be unavailable Replied, post #57 · Meta › Announcements · 28 Feb 2025 · 1 like Scheduled maintenance is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Cost per milligram, computed honestly across formats — the long version Replied, post #20 · Access › Pricing · 27 Feb 2025 · 0 likes Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies because pharmacies negotiate individually with insurers…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #100 · Compounds › Other compounds · 26 Feb 2025 · 9 likes Coming back to post #98, because the follow-up matters more than the original answer. Whatever the answer on Research-use-only status turns out to be, the method for…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #135 · Evidence › Journal club · 21 Feb 2025 · 5 likes Worth separating two things that post #131 runs together. I would call the community position on SURPASS-2 likely rather than established, and I would be comfortable…
Prior authorisation: what the criteria usually require Replied, post #7 · Access › Insurance & coverage · 17 Feb 2025 · 0 likes Taking post #6 at face value and following it one step further. Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #32 · Access › International · 7 Feb 2025 · 0 likes Bookmarking this. I will come back when I have something worth adding.
Triple agonism: additive, synergistic, or neither? Replied, post #12 · Compounds › Retatrutide · 21 Jan 2025 · 5 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
[2026 update] New subcategory: rationale and scope Replied, post #96 · Meta › Announcements · 26 Dec 2024 · 0 likes Where I have landed on New subcategory, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Started this topic · Compounds › Repair & healing peptides · 18 Dec 2024 · 7 likes On the subject in the title: BPC-157: what the rodent literature actually shows, and what it does not — a second dataset Working notes rather than a conclusion. The…
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #13 · Documentation › Doc review · 9 Dec 2024 · 19 likes No notes. Posting so the count is not one.
Why quantitation is the hard part, not detection Replied, post #2 · Analytics › Home & field testing · 8 Dec 2024 · 1 like Picking up the opening post: that is the part I would want checked first. Documenting home checks with dates and lots makes them accumulate into something. Undocumented…
People with a low starting BMI: where the evidence stops Replied, post #16 · Clinical › Special populations · 17 Nov 2024 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #34 · Sourcing › Independent verification · 16 Nov 2024 · 9 likes Coming back to post #30, because the follow-up matters more than the original answer. A record with four results over sixteen months is a thin record rather than a bad…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #66 · Compounds › Repair & healing peptides · 16 Nov 2024 · 8 likes On post #62 — agreed on the reasoning, with one qualification. The absence of adequately powered published randomised human trials is the central fact about BPC-157.…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #31 · Compounds › Repair & healing peptides · 11 Nov 2024 · 18 likes The reason reading a preclinical wound-healing model keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #6 · Compounds › Tirzepatide · 22 Oct 2024 · 4 likes On storage: published stability data covers the licensed formulation at its licensed concentration. A research preparation reconstituted at home in a different diluent…
What a seizure notice actually says Replied, post #2 · Sourcing › Logistics · 12 Oct 2024 · 0 likes Reframing seizure notice slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #65 · Practice › Dosing & titration · 17 Sep 2024 · 17 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #7 · Practice › Interactions · 10 Sep 2024 · 6 likes Post #4 is right about the mechanism and I think understates the practical bit. The most defensible general position in this subcategory: identify the plausible…
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #9 · Compounds › Secretagogues & GH axis · 8 Sep 2024 · 15 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
SURPASS-2 and the comparator dose question that will not go away Replied, post #2 · Compounds › Tirzepatide · 16 Aug 2024 · 0 likes Fair, and the limits you put on it are the part I will remember.
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #3 · Analytics › Method validation · 13 Jul 2024 · 8 likes Where I part company with the opening post, and it is a narrow parting. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of…
Follow-up: Why this community will not facilitate a group purchase Started this topic · Sourcing › Payments · 11 Jul 2024 · 0 likes Why this community will not facilitate a group purchase I have a specific reason for asking rather than idle curiosity, and the context is below. Currency and fees, set…